News

Published on 1 Nov 2024 on Insider Monkey · via Yahoo Finance

What Makes Regeneron Pharmaceuticals (REGN) an Attractive Investment...


Article preview image

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter...

NASDAQ.REGN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
What Makes Regeneron Pharmaceuticals (REGN) an Attractive Investment...

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarte...

Insider Monkey · via Yahoo Finance 1 Nov 2024

Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?

On Thursday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported third-quarter adjusted EPS of...

Benzinga · via Yahoo Finance 31 Oct 2024

Regeneron shares drop as higher-dose Eylea drug misses sales estimates

, opens new tab on Thursday reported weaker-than-expected quarterly sales of the higher dose vers...

Reuters 31 Oct 2024

Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight

Research and development expenses reflect a commitment to innovation, with a significant increase...

GuruFocus.com · via Yahoo Finance 31 Oct 2024

Recent Court Decision Supports Requiring Employees to Be In the Workplace –...

A recent Federal Court decision confirmed that the Family Medical Leave Act (FMLA) does not requi...

Central New York Business Journal 23 Oct 2024

Amgen to launch US Eylea biosimilar after ruling in Regeneron patent case

Amgen will launch its biosimilar version of Regeneron's blockbuster eye care drug Eylea following...

Reuters 22 Oct 2024

Teva Pharmaceuticals Agrees to Pay $450 Million to Resolve FCA Claims

On October 10, the US Department of Justice (DOJ) announced that Teva Pharmaceuticals USA Inc. an...

The National Law Review 18 Oct 2024

Regeneron Pharmaceuticals, Inc. (REGN): A Buzzing AI Health Stock to Add to Your...

We recently compiled a list of the 10 Buzzing AI Health Stocks. In this article, we are going to...

Insider Monkey · via Yahoo Finance 8 Oct 2024

Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) The Best Morgan Stanley...

We recently made a list of Morgan Stanley’s Best Overweight & Quality Stocks: Top 25 Stocks. In t...

Insider Monkey · via Yahoo Finance 8 Oct 2024

Insider Sale: Director Arthur Ryan Sells Shares of Regeneron Pharmaceuticals Inc...

On September 3, 2024, Arthur Ryan, Director at Regeneron Pharmaceuticals Inc (NASDAQ:REGN), execu...

GuruFocus.com · via Yahoo Finance 28 Aug 2024